How much does larotrectinib cost in domestic hospitals?

Larotrectinib is a targeted therapy drug used to treat a specific type of cancer, namely malignant tumors carrying NTRK gene fusions. This gene fusion is found in a variety of cancer types, including infantile fibrosarcoma, adult soft tissue sarcoma, thyroid cancer, and pancreatic cancer. Larotrectinib inhibits the growth and spread of tumors by targeting the activity of NTRK fusion proteins, thereby providing new hope for the treatment of patients.

In the domestic market, larotrectinib has been launched and is used in clinical treatment by some hospitals. However, because it is a new type of drug and has significant therapeutic effects, its price is relatively high. According to market research, the price of larotrectinib sold in domestic hospitals is roughly between 10,000 yuan and 20,000 yuan. The specific price may vary depending on the region, hospital or manufacturer. In addition, larotrectinib is currently not covered by medical insurance, so patients need to purchase it at their own expense.

For patients and their families, the high price of larotrectinib may constitute a certain financial burden. However, for patients with rare cancers who carry NTRK gene fusions, larotrectinib may be one of their best treatment options, and patients may consider more economical generic drugs. Compared with traditional chemotherapy or radiotherapy regimens, larotrectinib has a more precise targeting effect and can effectively reduce damage to healthy tissue while improving treatment effects and survival rates.

When choosing whether to use larotrectinib, patients and their families should fully communicate and discuss with their doctors, comprehensively consider factors such as treatment effects, side effects, and financial affordability, and make rational decisions. Also, other possible payment options or drug assistance programs can be explored to ease the financial burden.

In general, larotrectinib, as a new type of targeted therapy, has shown good efficacy in treating specific types of cancer. Despite its higher price, it may be a promising path for some patients. It is hoped that with the continuous advancement of medical technology and the improvement of medical insurance policies, more reasonable treatment options can be provided for more patients.